Free Trial

Accuray (ARAY) Competitors

Accuray logo
$1.62 -0.13 (-7.18%)
As of 02:55 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ARAY vs. OFIX, ANGO, SRDX, RMTI, RSLS, ABT, ISRG, BSX, SYK, and MDT

Should you be buying Accuray stock or one of its competitors? The main competitors of Accuray include Orthofix Medical (OFIX), AngioDynamics (ANGO), Surmodics (SRDX), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), and Medtronic (MDT). These companies are all part of the "health care equipment" industry.

Accuray vs.

Orthofix Medical (NASDAQ:OFIX) and Accuray (NASDAQ:ARAY) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, dividends, community ranking, media sentiment, risk, analyst recommendations, valuation and institutional ownership.

Accuray has lower revenue, but higher earnings than Orthofix Medical. Accuray is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Orthofix Medical$804.53M0.58-$151.40M-$3.69-3.25
Accuray$465.25M0.39-$15.55M-$0.05-34.80

Orthofix Medical presently has a consensus target price of $23.33, suggesting a potential upside of 94.61%. Given Orthofix Medical's stronger consensus rating and higher possible upside, research analysts plainly believe Orthofix Medical is more favorable than Accuray.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Orthofix Medical
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Accuray
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Accuray has a net margin of -0.96% compared to Orthofix Medical's net margin of -15.18%. Accuray's return on equity of -9.75% beat Orthofix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Orthofix Medical-15.18% -21.25% -13.29%
Accuray -0.96%-9.75%-0.93%

In the previous week, Orthofix Medical had 1 more articles in the media than Accuray. MarketBeat recorded 3 mentions for Orthofix Medical and 2 mentions for Accuray. Orthofix Medical's average media sentiment score of 1.80 beat Accuray's score of 1.06 indicating that Orthofix Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Orthofix Medical
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Accuray
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Orthofix Medical received 81 more outperform votes than Accuray when rated by MarketBeat users. However, 65.44% of users gave Accuray an outperform vote while only 62.11% of users gave Orthofix Medical an outperform vote.

CompanyUnderperformOutperform
Orthofix MedicalOutperform Votes
418
62.11%
Underperform Votes
255
37.89%
AccurayOutperform Votes
337
65.44%
Underperform Votes
178
34.56%

89.8% of Orthofix Medical shares are owned by institutional investors. Comparatively, 64.1% of Accuray shares are owned by institutional investors. 1.3% of Orthofix Medical shares are owned by insiders. Comparatively, 4.2% of Accuray shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Orthofix Medical has a beta of 0.87, meaning that its share price is 13% less volatile than the S&P 500. Comparatively, Accuray has a beta of 1.3, meaning that its share price is 30% more volatile than the S&P 500.

Summary

Orthofix Medical beats Accuray on 10 of the 18 factors compared between the two stocks.

Get Accuray News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARAY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ARAY vs. The Competition

MetricAccuraySurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$179.24M$4.54B$5.43B$8.48B
Dividend YieldN/A43.65%5.22%4.11%
P/E Ratio-34.8029.8726.8220.05
Price / Sales0.3970.43393.28116.44
Price / CashN/A51.0838.2534.62
Price / Book3.876.346.874.61
Net Income-$15.55M$67.64M$3.22B$248.19M
7 Day Performance9.43%21.94%6.81%2.97%
1 Month Performance20.00%26.54%13.71%16.58%
1 Year Performance14.47%22.75%18.30%8.16%

Accuray Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ARAY
Accuray
2.4384 of 5 stars
$1.62
-7.2%
N/A+8.7%$166.37M$465.25M-32.301,040Analyst Downgrade
Gap Up
OFIX
Orthofix Medical
3.4931 of 5 stars
$12.43
+2.6%
$23.33
+87.7%
-20.6%$485.04M$804.53M-3.971,090Gap Up
ANGO
AngioDynamics
4.4821 of 5 stars
$9.57
+5.0%
$14.00
+46.3%
+63.7%$388.61M$283.32M-1.70760News Coverage
Positive News
SRDX
Surmodics
4.2927 of 5 stars
$27.09
+1.2%
$43.00
+58.7%
-15.3%$387.36M$121.58M-26.82450Positive News
RMTI
Rockwell Medical
4.1944 of 5 stars
$1.04
-7.1%
$4.00
+284.6%
-40.6%$35.54M$101.49M-20.80300Analyst Revision
Gap Up
RSLS
ReShape Lifesciences
0.2413 of 5 stars
$6.01
-9.8%
N/A-98.1%$2.71M$8.01M-0.0250News Coverage
Earnings Report
Gap Down
ABT
Abbott Laboratories
4.8926 of 5 stars
$131.90
-1.0%
$142.59
+8.1%
+30.9%$229.49B$42.34B17.24115,000News Coverage
Positive News
ISRG
Intuitive Surgical
4.327 of 5 stars
$561.43
+4.6%
$598.95
+6.7%
+39.3%$201.23B$8.71B87.5912,100Positive News
BSX
Boston Scientific
4.2424 of 5 stars
$102.76
-0.1%
$114.52
+11.4%
+41.3%$152.02B$17.55B82.2145,000Positive News
Options Volume
SYK
Stryker
4.9296 of 5 stars
$387.97
+1.9%
$427.05
+10.1%
+18.1%$148.08B$23.22B50.0051,000Trending News
MDT
Medtronic
4.5332 of 5 stars
$85.70
+2.7%
$96.14
+12.2%
+1.9%$109.91B$33.20B26.0595,000Trending News
Earnings Report
Dividend Increase
Analyst Forecast
Options Volume

Related Companies and Tools


This page (NASDAQ:ARAY) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners